Influence of an exercise program on cardiac function of patients with Stroke.
Not Applicable
- Conditions
- StrokeC10.228.140.300.775
- Registration Number
- RBR-4wk4b3
- Lead Sponsor
- Faculdade de Medicina de Botucatu (FMB) - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Will be included participants older than 18 years; both sexes; ischemic stroke or TIA; modified Rankin scale (mRS less or equal 2); chronic phase (6 to 12 months of the onset of symptoms); clinically stable for the study after medical approval.
Exclusion Criteria
Patients with hemorrhagic stroke; mRS more than 2; uncontrolled hypertension (systolic blood pressure more than 150 mm Hg); history of angina in the last three months; uncontrolled epilepsy; heart rate of persistent atrial fibrillation or permanent and/or rate of artificial pacemaker; presence of mitral and/or aortic valvular stenosis; presence of heart failure grade IV - stage D; chronic obstructive pulmonary disease (COPD); life expectancy less than 6 months.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement equal to or above 300 meters in the walk test of six minutes in the next week after 16 weeks of intervention.
- Secondary Outcome Measures
Name Time Method a) Neurological evaluation: improvement in 15% of NIHSS, mRS and Barthel scales after the intervention;<br><br>b) Nutritional assessment: improvement in range of 5 to 10% of total body fat rate after the intervention;<br><br>c) Cardiologic evaluation: improvement in left ventricular mass of 8 to 12 g/m2.7 the echocardiogram after the intervention, and decrease in 7 mmHg of the systolic blood pressure and 5 mmHg of diastolic blood pressure by ambulatory blood pressure monitoring (ABPM) after the intervention;<br><br>d) Laboratory tests: improvement of the inflammatory response in the range of 30 to 50% after the intervention;<br><br>e) Quality of life: improvement in 15% of the perception on the scale of quality of life after the intervention.<br><br><br><br>